COVID-19 and Chilblains

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

269 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-21

Study Completion Date

2020-10-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chilblains (inflammatory lesion of the feet or hands) have been reported with an unusual frequency during the confinement period, most commonly in children, teenagers and young adults. The aim of the ECCES study is to find out whether these manifestations of chilblains can be linked to the SARS-CoV-2 coronavirus.

For this, an epidemiologic study will compare two types of family (or more precisely people who were confined together in March-April-May):

* "case family" in which at least one of the members had chilblains
* "comparator family" in which none of the members had chilblains Environment (home lockdown) of the two types of family will be analyzed. Each member of the "family" will be suggested doing a serological test.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Chilbains Occuring During Covid-19 Infection

NCT04344119

Skin Manifestations COVID Chilblains

UNKNOWN

Impact of COVID-19 on Occupational Dermato-allergology Consultations of Health Peronnel

NCT06237010

Dermatoses Health Workers

COMPLETED

Hand Eczema in the Health Care Sector

NCT04449575

Hand Eczema

UNKNOWN

Paraffin Bath Therapy for Chronic Hand Eczema

NCT04510961

Eczema

COMPLETED NA

Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis

NCT01706913

Cellulitis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chilblains COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects with chilblains

Group Type EXPERIMENTAL

Biological sample collection

Intervention Type OTHER

10mL blood sample

Subjects without chilblains

Group Type ACTIVE_COMPARATOR

Biological sample collection

Intervention Type OTHER

10mL blood sample

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biological sample collection

10mL blood sample

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* "case family"
* at least one of the members with chilblains
* diagnosis of chilblains (anamnesis and pictures) written informed consent
* "comparator family"
* none of the members with chilblains
* one member matched on age (+/- 1 year) to a patient with chilblains
* written informed consent